Almirall (ALM.MC) Market Summary

  • Trading Activity: Almirall shares traded down 0.3 % during the 24‑hour period ending at 03:29 AM Central European Time on Thursday, 22 April 2026.
  • Current Price: EUR 10.38 per share.
  • Market Capitalisation: EUR 2.2 billion.
  • Shares Outstanding: 217.6 million.
  • Volume: Approximately EUR 1 million of Almirall shares were traded in the last 24 hours.
  • Short‑Term Performance: Since the close of the previous month, Almirall shares are down 5.75 %.
  • Moving Average: The simple moving average over the last 200 days is EUR 11.57.
  • 52‑Week Range: The highest price in the past 52 weeks was EUR 13.98 on 19 February 2026; the lowest price was EUR 9.81 on 13 October 2026.

Comparison with Peer Stocks (24‑Hour Performance)

StockTicker24‑Hour ChangeCurrent PriceMarket CapitalisationP/E Ratio
Melia HotelsMEL.MC–0.39 %EUR 10.47EUR 2.3 bn13.59
Arteche Lantegi ElkarteaART.MC–1.52 %EUR 32.2EUR 1.9 bn47.14
HbxHBX.MC–0.83 %EUR 7.9EUR 1.8 bn9.98
Grenergy RenovablesGRE.MC–5.65 %EUR 66.2EUR 1.9 bn14.95
Cementos MolinsCMO.MC+8.05 %EUR 37.6EUR 2.2 bn10.12

Company Profile

Almirall SA Almirall SA is a pharmaceutical company that researches, develops, manufactures, and sells medicines globally. The company’s product portfolio focuses on dermatological conditions—including actinic keratosis, atopic dermatitis, acne, rosacea, and psoriasis—as well as central nervous system, cardiovascular, and gastrointestinal diseases. Key therapeutic brands include ACTIKERALL, BALNEUM, DECODERM, SATIVEX, SKILARENCE, and DECODERM.

  • Founded: 1943
  • Headquarters: Barcelona, Spain
  • Website: www.almirall.com
  • Stock Exchange Listing: Bolsa De Madrid (ticker: ALM.MC)
  • Initial Public Offering: 20 June 2007

The information above reflects the most recent trading data and company disclosures available as of the specified date.